COMBINED POLY(ISOBUTYLCYANOACRYLATE) AND CYCLODEXTRINS NANOPARTICLES FOR ENHANCING THE ENCAPSULATION OF LIPOPHILIC DRUGS

Citation
Am. Dasilveira et al., COMBINED POLY(ISOBUTYLCYANOACRYLATE) AND CYCLODEXTRINS NANOPARTICLES FOR ENHANCING THE ENCAPSULATION OF LIPOPHILIC DRUGS, Pharmaceutical research, 15(7), 1998, pp. 1051-1055
Citations number
14
Categorie Soggetti
Pharmacology & Pharmacy",Chemistry
Journal title
ISSN journal
07248741
Volume
15
Issue
7
Year of publication
1998
Pages
1051 - 1055
Database
ISI
SICI code
0724-8741(1998)15:7<1051:CPACNF>2.0.ZU;2-2
Abstract
Purpose. The aim of this study was to prepare and characterize nano-pa rticulate systems constituted of poly(isobutylcyanoacrylate) and cyclo dextrins and intended for increasing the loading of the particles with lipophilic substances. Progesterone was used as a model substance. Me thods. Nanoparticles were prepared by polymerization of isobutylcyanoa crylate in presence of cyclodextrins or progesterone/hydroxypropyl-bet a-cyclodextrin complex. Particle size, zeta potential, cyclodextrin an d progesterone loading of the particles were determined. Results. Nano particles could be easily prepared in presence of cyclodextrins. An in crease in hydroxypropyl-beta-cyclodextrin concentration resulted in sm all nanoparticles (less than 50 nm). It was found that large amounts o f cyclodextrins remained associated to the particles, resulting in a 5 0 fold increase in progesterone loading compared to nanoparticles prep ared in absence of cyclodextrins. Conclusions. The poly(isobutylcyanoa crylate)-cyclodextrin nanoparticles were characterized by the presence of many lipophilic sites belonging to the cyclodextrins which were fi rmly anchored to the structure of the particles. Therefore, this new t ype of nanoparticles offers probably an opportunity for increasing the loading of nanoparticles with various lipophilic drugs.